These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Majić T; Schmidt TT; Gallinat J J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401 [TBL] [Abstract][Full Text] [Related]
6. Chemistry and Structure-Activity Relationships of Psychedelics. Nichols DE Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524 [TBL] [Abstract][Full Text] [Related]
7. Psychedelics: Where we are now, why we got here, what we must do. Belouin SJ; Henningfield JE Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779 [TBL] [Abstract][Full Text] [Related]
8. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action. Canal CE Handb Exp Pharmacol; 2018; 252():227-260. PubMed ID: 29532180 [TBL] [Abstract][Full Text] [Related]
11. The renaissance in psychedelic research: What do preclinical models have to offer. Murnane KS Prog Brain Res; 2018; 242():25-67. PubMed ID: 30471682 [TBL] [Abstract][Full Text] [Related]
13. Towards an understanding of psychedelic-induced neuroplasticity. Calder AE; Hasler G Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427 [TBL] [Abstract][Full Text] [Related]
14. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A Elife; 2018 Oct; 7():. PubMed ID: 30355445 [TBL] [Abstract][Full Text] [Related]
16. Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health. Barnett BS J Psychopharmacol; 2022 Oct; 36(10):1097-1099. PubMed ID: 36112818 [TBL] [Abstract][Full Text] [Related]
17. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717 [TBL] [Abstract][Full Text] [Related]